CD4 and tuberculosis: Our findings are also consistent with another large observational database which reported a non-significant impact of delayed ART initiation among HIV-TB co-infected patients on mortality.[4] The primary endpoint of the global STRIDE study demonstrated the benefit of early ART initiation among patients with CD4 cell counts less than 50 cells per cumm, however the primary endpoint was new AIDS-defining illness or death.[12]